Knowing which drugs to avoid or monitor helps ensure safe, successful treatment
Frequently studied in neurobiology contexts related to sleep/circadian research models and stress-axis signaling themes (model-dependent)
Robert Popovian in Washington, D.C
on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
You may be an ideal candidate if: You have a body mass index (BMI) of 27 or higher, with or without related health conditions You have tried multiple diets without achieving lasting results You have been diagnosed with obesity-related conditions such as type 2 diabetes, hypertension, or sleep apnea You need to lose more than 20 pounds under safe, supervised conditions You are interested in weight loss medications such as semaglutide or tirzepatide but want physician oversight The best way to confirm candidacy is through a consultation at our office
Low libido ( aka hypoactive sexual desire disorder) is a common complaint among women